New Approaches to Treatment for Multiple Myeloma: Durable Remission and Quality of Life as Primary Goals
- 1 November 2005
- journal article
- review article
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 6 (3), 181-190
- https://doi.org/10.3816/clm.2005.n.045
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Single versus Double Autologous Stem-Cell Transplantation for Multiple MyelomaNew England Journal of Medicine, 2003
- Treatment of Plasma Cell Dyscrasias With Thalidomide and Its DerivativesJournal of Clinical Oncology, 2003
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaNew England Journal of Medicine, 2003
- Thalidomide Alone or With Dexamethasone for Previously Untreated Multiple MyelomaJournal of Clinical Oncology, 2003
- Thalidomide in multiple myeloma: current status and future prospectsBritish Journal of Haematology, 2002
- Combination Therapy With Thalidomide Plus Dexamethasone for Newly Diagnosed MyelomaJournal of Clinical Oncology, 2002
- Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomaBlood, 2002
- Antitumor Activity of Thalidomide in Refractory Multiple MyelomaNew England Journal of Medicine, 1999
- A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple MyelomaNew England Journal of Medicine, 1996
- REAPPRAISAL OF PLATEAU PHASE IN MYELOMAThe Lancet, 1980